Literature DB >> 1330933

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain.

N Muñoz1, F X Bosch, S de Sanjosé, L Tafur, I Izarzugaza, M Gili, P Viladiu, C Navarro, C Martos, N Ascunce.   

Abstract

To evaluate the association between human papillomavirus (HPV) and cervical cancer, we performed a population-based case-control study in Columbia and Spain, the former country having an incidence rate of cervical cancer about 8 times higher than the latter. It included 436 cases of histologically confirmed invasive cervical cancer and 387 randomly selected population controls. Information on demographic variables, sexual behaviour and other risk factors was obtained by interview. HPV-DNA was measured in cervical-swab specimens with 3 hybridization assays: ViraPap, Southern hybridization (SH) and polymerase chain reaction (PCR). The presence of HPV-DNA and detection of types 16, 18, 31, 33 and 35 were strongly associated with cervical cancer in each country regardless of the assay used. For both countries combined the adjusted odds ratios and 95% confidence intervals were: ViraPap OR = 25.9 (10.0-66.7); SH OR = 6.8 (3.4-13.4); and PCR OR = 28.8 (15.7-52.6). HPV-16 was the most common type detected in both cases and controls. Our results indicate that there is a very strong association between HPV 16, 18, 31, 33 and 35 and invasive cervical cancer and that this association is probably causal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330933     DOI: 10.1002/ijc.2910520513

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  104 in total

1.  Screening for cervical cancer: should we test for infection with high-risk HPV?

Authors:  C J Meijer; P J Snijders; A J van den Brule
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

2.  Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.

Authors:  J U Cope; A Hildesheim; M H Schiffman; M M Manos; A T Lörincz; R D Burk; A G Glass; C Greer; J Buckland; K Helgesen; D R Scott; M E Sherman; R J Kurman; K L Liaw
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Does human papillomavirus cause pterygium?

Authors:  T W Reid; N Dushku
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

4.  Methods of model calibration: observations from a mathematical model of cervical cancer.

Authors:  Douglas C A Taylor; Vivek Pawar; Denise Kruzikas; Kristen E Gilmore; Ankur Pandya; Rowan Iskandar; Milton C Weinstein
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.

Authors:  Tanvier Omar; Sheree Schwartz; Colleen Hanrahan; Tebogo Modisenyane; Nkeko Tshabangu; Jonathan E Golub; James A McIntyre; Glenda E Gray; Lerato Mohapi; Neil A Martinson
Journal:  AIDS       Date:  2011-01-02       Impact factor: 4.177

6.  Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection.

Authors:  Troy J Kemp; Allan Hildesheim; Alfonso García-Piñeres; Marcus C Williams; Gene M Shearer; Ana Cecilia Rodriguez; Mark Schiffman; Robert Burk; Enrique Freer; Jose Bonilla; Rolando Herrero; Ligia A Pinto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

7.  [Screening for cancer].

Authors:  U Seifert; U Schlanstedt-Jahn; S J Klug
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

8.  HPV and p53 in cervical cancer.

Authors:  H Y Ngan; M Stanley; S S Liu; H K Ma
Journal:  Genitourin Med       Date:  1994-06

9.  Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.

Authors:  Eduardo L Franco; Joseph Tota
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

10.  Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.

Authors:  R A Hanisch; P S Sow; M Toure; A Dem; B Dembele; P Toure; R L Winer; J P Hughes; G S Gottlieb; Q Feng; N B Kiviat; S E Hawes
Journal:  J Clin Virol       Date:  2013-10-18       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.